Research
Noom is grounded in science.
Evidence-Based Science
We have more than 40 peer-reviewed scientific articles that inform users, practitioners, scientists, and the public about how our methods work and how effective they are, as well as provide more general observational information that contributes to science.
Our team of behavioral health experts have PhDs and masters degrees in psychology, neuroscience, and statistics. We make scientific discoveries about all aspects of behavior change, making the world a healthier place.
Our research spans many different areas of health, including oncology, diabetes prevention, hypertension, diabetes management, and more.
Featured Publications
Peer-Reviewed Scientific Journal Articles
JMIR mHealth.
2020
Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial
Health Education & Behavior.
2021
Men’s Weight Loss Outcomes, Behaviors, and Perceptions in Self-Directed Commercial Mobile Program: Retrospective Analysis
JMIR Formative.
2022
Noom Mood: Feasibility, Acceptability, and Preliminary Outcomes of a CBT-based Mobile Mental Well-being Program
IJERPH.
2022
Executive Function-Related Improvements on a Commercial CBT-Based Weight Management Intervention: Pilot Randomized Controlled Trial
Participate in Research
We’re currently running studies that explore all aspects of behavior change to make the world a healthier place.
Research on Diabetes
The Noom Diabetes Prevention Program (DPP) was the first virtual DPP to receive full CDC recognition.
Have questions?
Please email research@noom.com
Analysis
The Latest Insights
The latest data on how behavior change can improve health, brought to you by Noom’s research scientists.
When we’re not working on scientific publications, we explore interesting data trends and learn fun insights from our users. Want to know how food consumption changed around the latest holiday, or the trending new snacks this year?
Check back often for our latest analyses.
Wegovy® pill: Exploring the benefits, side effects, and cost
What you’ll learn: The Wegovy® pill is the first FDA-approved oral GLP-1 medication for weight loss, offering a daily, needle-free alternative to weekly injections. People lose an average of 14% of body weight in about 64 weeks...
Rybelsus® cost without insurance: What to expect in 2026
What you’ll learn: Rybelsus®, made with semaglutide, is the only GLP-1 pill approved for diabetes management. Most people without insurance pay around $950 to $1,100 per month for Rybelsus®. Manufacturer savings programs...
Does tirzepatide make you tired? What you need to know
What you’ll learn: Fatigue is a possible side effect of tirzepatide, but it’s relatively uncommon, affecting about 5 to 7% of people. When tiredness does happen, it’s usually linked to dose adjustments, eating fewer calories,...
SCIENCE SPOTLIGHT
Can sense of smell impact health and weight?
A recent study showed that mice who’ve lost their sense of smell had a faster metabolism, better fat-burning, and lower obesity than mice with normal noses.
What does this mean?
This study was done on mice, so it’s too early to say whether you should start holding your nose while eating lunch. However, it does suggest that smell isn’t just about enjoying your meal, it can also trigger your body to build up fat stores.
Contact Us
Thanks for your interest in Noom.
Please use the form below if you have questions about our research or would like to partner and contribute to our science.
If you’d like to partner with us, please let us know about your research interests and what kind of collaboration you’re envisioning.
"*" indicates required fields
